CLDN18 and jejunal neoplasm: Moreover, CLDN18 expression was less frequent in CoD-SBAs (7%) in comparison with CrD-SBAs (39%) and Spo-SBAs (29%) and less common in jejunal tumours (13%) in comparison with duodenal (30%) or ileal (39%) SBAs, although these differences did not reach statistical significance.